Six confirmed cases of autochthonous Chikungunya have prompted a health alert in French Guiana, with authorities initiating enhanced vector control measures and urging public vigilance. The cases, detected since January 23, 2026, represent a resurgence of the virus after a period of dormancy following a major epidemic in 2014, according to the Agence Régionale de Santé (ARS) Guyane.
The ARS issued an urgent public health message on February 4, 2026, detailing the situation and activating its response protocol. The cases are geographically dispersed, appearing in distinct sectors, suggesting established, though previously undetected, viral circulation. This contrasts with previous instances where cases were primarily linked to travelers returning from regions with active transmission, such as the Indian Ocean island of Réunion, where cases were reported in April 2025.
“The most key measure is the detection of cases,” stated Préfecture Antoine Poussier, emphasizing the immediate transmission of each confirmed case to the Collectivité Territoriale de Guyane (CTG) for targeted mosquito control. These interventions focus on eliminating larval breeding sites around the residences of those infected.
The CTG is responsible for the vector control operations, deploying spraying teams in Saint-Laurent-du-Maroni, where efforts are being concentrated. Teams operate between 4:00 AM and 6:30 AM, systematically covering designated sectors. This response is informed by the situation in neighboring Suriname, which is currently experiencing a significant outbreak with over one hundred cases reported.
The ARS is urging healthcare professionals to report any biologically confirmed cases immediately to the regional focal point, enabling prompt investigation and tailored management measures. The reporting of confirmed Chikungunya cases is mandatory. Patients are also being advised to seize appropriate precautions to avoid mosquito bites and prevent further transmission.
Chikungunya virus is transmitted to humans by Aedes mosquitoes, which also carry Dengue and Zika viruses. Symptoms typically appear 5 to 7 days after a bite and include high fever, muscle and joint pain (often debilitating), fatigue, headache and potentially skin rashes or bleeding. Medical consultation is strongly advised at the onset of high fever and severe joint pain.
The ARS has not yet announced a timeline for the intensified control measures, and further updates are expected as the situation evolves. The agency is continuing to monitor the spread of the virus and assess the effectiveness of the current response.
